Treatment with a spinal cord stimulation system reduced pain and restored sensory nerve function in a small cohort of ...

Boston Scientific Corporation develops ... neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ...

An estimated 18,000 people in the United States annually suffer from new injuries to their spinal cords. Unfortunately for ...

If this kind of company isn't your style, you like companies that generate revenue, and even earn profits, then you may well be interested in Boston Scientific (NYSE:BSX). While profit isn't the ...

Boston Scientific Corporation (BSX)’s share was trading at $94.27 as of April 14th. BSX’s trailing and forward P/E were 75.42 and 33.11 respectively according to Yahoo Finance. Boston ...

Needham upgraded Boston Scientific (BSX) to Buy from Hold with a $113 price target Needham’s latest electrophysiologist survey shows the threat of pulsed field ablation competition appears less ...

Scientists at UC San Diego are looking into the body's healing mechanisms for clues on recovery from spinal cord injury. A new study by researchers in the Department of Neurobiology (School of ...

Investing.com -- Needham upgraded Boston Scientific Corp (NYSE:BSX) to “Buy”, saying competition from pulsed field ablation (PFA) rivals looks less intense for its key product than it was earlier ...

Boston Scientific Corporation (BSX) develops, manufactures & markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg & Cardiovascular ...